Clinical Trials Directory

Trials / Unknown

UnknownNCT02880787

Comparison of Two Neuromuscular Transmission Monitors Based on Acceleromyography: TOF-Watch SX® and TOFScan®

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
142 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
1 Year
Healthy volunteers
Not accepted

Summary

The purpose is to evaluate the reproducibility of neuromuscular monitoring data of recovery from neuromuscular blockade, obtained with TOFScan® and TOF-Watch SX®, in adult and pediatric population. Secondary purposes are to evaluate the reproducibility of data obtained with 2 monitors for: * the onset of clinical action of curare: suppression of the first response of train of four monitoring (T1) of 95% initial value * the duration of clinical action of curare: recovery of the first response of train of four monitoring (T1) to 25% initial value * recovery of first (T1), second (T2), third (T3) and fourth response (T4) of train of four monitoring, and recovery of T4/T1 to 40% and 60% initial value (T4/T1 0.4 and 0.6) * complete recovery from curarisation, at T4/T1=90% and T4/T1=100%.

Conditions

Interventions

TypeNameDescription
DRUGRocuroniumAnesthesia induction with Propofol and maintaining with desflurane. For adult patients, the curare is rocuronium (0.6 mg/kg) For pediatric patients, the curare can be rocuronium (0.6 mg/kg), cisatracurium (0.1 mg/kg) or atracurium (0.5 mg/kg)
DEVICENeuromuscular monitoring with TOFScan® and TOF-Watch SX®Each monitor on one arm

Timeline

Start date
2014-11-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-08-26
Last updated
2016-08-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02880787. Inclusion in this directory is not an endorsement.